Literature DB >> 19362712

TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.

Michael G Drage1, Nicole D Pecora, Amy G Hise, Maria Febbraio, Roy L Silverstein, Douglas T Golenbock, W Henry Boom, Clifford V Harding.   

Abstract

Mycobacterium tuberculosis (Mtb) signals through Toll-like receptor 2 (TLR2) to regulate antigen presenting cells (APCs). Mtb lipoproteins, including LpqH, LprA, LprG and PhoS1, are TLR2 agonists, but their co-receptor requirements are unknown. We studied Mtb lipoprotein-induced responses in TLR2(-/-), TLR1(-/-), TLR6(-/-), CD14(-/-) and CD36(-/-) macrophages. Responses to LprA, LprG, LpqH and PhoS1 were completely dependent on TLR2. LprG, LpqH, and PhoS1 were dependent on TLR1, but LprA did not require TLR1. None of the lipoproteins required TLR6, although a redundant contribution by TLR6 cannot be excluded. CD14 contributed to detection of LprA, LprG and LpqH, whereas CD36 contributed only to detection of LprA. Studies of lung APC subsets revealed lower TLR2 expression by CD11b(high)/CD11c(low) lung macrophages than CD11b(low)/CD11c(high) alveolar macrophages, which correlated with hyporesponsiveness of lung macrophages to LpqH. Thus, lung APC subsets differ in TLR expression, which may determine differences in responses to Mtb.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362712      PMCID: PMC2730726          DOI: 10.1016/j.cellimm.2009.03.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  46 in total

Review 1.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  E H Noss; R K Pai; T J Sellati; J D Radolf; J Belisle; D T Golenbock; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.

Authors:  P Henneke; O Takeuchi; J A van Strijp; H K Guttormsen; J A Smith; A B Schromm; T A Espevik; S Akira; V Nizet; D L Kasper; D T Golenbock
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

5.  Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38.

Authors:  Thierry Vasselon; William A Hanlon; Samuel D Wright; Patricia A Detmers
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

6.  Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.

Authors:  Norbert Reiling; Christoph Hölscher; Alexandra Fehrenbach; Svenja Kröger; Carsten J Kirschning; Sanna Goyert; Stefan Ehlers
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.

Authors:  Osamu Takeuchi; Shintaro Sato; Takao Horiuchi; Katsuaki Hoshino; Kiyoshi Takeda; Zhongyun Dong; Robert L Modlin; Shizuo Akira
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.

Authors:  Lena Alexopoulou; Venetta Thomas; Markus Schnare; Yves Lobet; Juan Anguita; Robert T Schoen; Ruslan Medzhitov; Erol Fikrig; Richard A Flavell
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

9.  Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers.

Authors:  Trude H Flo; Liv Ryan; Eicke Latz; Osamu Takeuchi; Brian G Monks; Egil Lien; Øyvind Halaas; Shizuo Akira; Gudmund Skjåk-Braek; Douglas T Golenbock; Terje Espevik
Journal:  J Biol Chem       Date:  2002-06-27       Impact factor: 5.157

10.  Ganglioside GD1a is an essential coreceptor for Toll-like receptor 2 signaling in response to the B subunit of type IIb enterotoxin.

Authors:  Shuang Liang; Min Wang; Richard I Tapping; Vitaly Stepensky; Hesham F Nawar; Martha Triantafilou; Kathy Triantafilou; Terry D Connell; George Hajishengallis
Journal:  J Biol Chem       Date:  2007-01-16       Impact factor: 5.157

View more
  75 in total

1.  Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Authors:  Christina L Lancioni; Qing Li; Jeremy J Thomas; XueDong Ding; Bonnie Thiel; Michael G Drage; Nicole D Pecora; Assem G Ziady; Samuel Shank; Clifford V Harding; W Henry Boom; Roxana E Rojas
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages.

Authors:  Françoise Debierre-Grockiego; Sebastian Niehus; Bernadette Coddeville; Elisabeth Elass; Françoise Poirier; Ralf Weingart; Richard R Schmidt; Joël Mazurier; Yann Guérardel; Ralph T Schwarz
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 3.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

Review 4.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

Review 5.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

6.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

7.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.

Authors:  Henry W Murray; Yunhua Zhang; Yan Zhang; Vanitha S Raman; Steven G Reed; Xiaojing Ma
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

8.  Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2+ Monocytes.

Authors:  Christopher T Johndrow; Michael F Goldberg; Alison J Johnson; Tony W Ng; Shajo Kunnath-Velayudhan; Gregoire Lauvau; Daniel H Kaplan; Graeme H Gossel; Ulrich D Kadolsky; Andrew J Yates; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2018-11-19       Impact factor: 5.422

9.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

10.  Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Authors:  Mohan R Dasu; Sridevi Devaraj; Samuel Park; Ishwarlal Jialal
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.